Susquehanna International »

Plus Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2025-09-30 $46k 67k 0.68
2025-03-31 $77k 81k 0.95

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
UnitedHealth (UNH)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Palantir Technologies Cl A (PLTR)
Broadcom (AVGO)

View all positions for Susquehanna International

Top funds holding Plus Therapeutics

Vanguard Group
Altium Capital Management
Geode Capital Management
UBS Group
BlackRock
State Street Corporation
Northern Trust
Scientech Research
Susquehanna International
Mercer Global Advisors
Dagco
Kestra Advisory Services
Cubist Systematic Strategies
Two Sigma Securities
Cambridge Investment Research Advisors

View all funds holding Plus Therapeutics